Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1992-11-23
pubmed:abstractText
1. The M-like current IK(M,ng) in differentiated NG108-15 mouse neuroblastoma x rat glioma hybrid cells has been studied using tight-seal, whole-cell patch-clamp recording. 2. When calculated from steady-state current-voltage curves, the conductance underlying IK(M,ng) showed a Boltzmann dependence on voltage with half-activation voltage Vo = -44 mV (in 3 mM [K+]) and slope factor (a) = 8.1 mV/e-fold increase in conductance. In 12 mM [K+] Vo = -38 mV and a = 6.9 mV. The deactivation reciprocal time constant accelerated with hyperpolarization with slope factor 17 mV/e-fold voltage change. 3. The reversal potential for deactivation tail currents varied with external [K+] as if PNa/PK were 0.005. 4. Steady-state current was increased on removing external Ca2+. In the presence of external Ca2+, reactivation of IK(M, ng) after a hyperpolarizing step was delayed. This delay was preceded by an inward Ca2+ current, and coincided with an increase in intracellular [Ca2+] as measured with Indo-1 fluorescence. Elevation of intracellular [Ca2+] with caffeine also reduced IK(M, ng). 5. IK(M, ng) was inhibited by external divalent cations in decreasing order of potency (mM IC50 in parentheses): Zn2+ (0.011) greater than Cu2+ (0.018) greater than Cd2+ (0.070) greater than Ni2+ (0.44) greater than Ba2+ (0.47) greater than Fe2+ (0.69) greater than Mn2+ (0.86) greater than Co2+ (0.92) greater than Ca2+ (5.6) greater than Mg2+ (16) greater than Sr2+ (33). This was not secondary to inhibition of ICa since: (i) inhibition persisted in Ca(2+)-free solution; (ii) La3+ did not inhibit IK(M, ng) at concentrations which inhibited ICa; and (iii) organic Ca2+ channel blockers were ineffective. Inhibition comprised both depression of the maximum conductance and a positive shift of the activation curve. Addition of Ca2+ (10 microM free [Ca2+]) or Ba2+ (1 mM total [Ba2+]) to the pipette solution did not significantly change IK(M, ng). 6. IK(M, ng) was reduced by 9-amino-1,2,3,4-tetrahydroacridine (IC50 8 microM) and quinine (30 microM) but was insensitive to tetraethylammonium (IC50 greater than 30 mM), 4-aminopyridine (greater than 10 mM), apamin (greater than 3 microM) or dendrotoxin (greater than 100 nM). 7. IK(M, ng) was inhibited by bradykinin (1-10 microM) or angiotensin II (1-10 microM), but not by the following other receptor agonists: acetylcholine (10 mM), muscarine (10 microM), noradrenaline (100 microM), adrenaline (100 microM), dopamine (100 microM), histamine (100 microM), 5-hydroxytryptamine (10 microM), Met-enkephalin (1 microM), glycine (100 microM), gamma-aminobutyric acid (100 microM) or baclofen (500 microM).(ABSTRACT TRUNCATED AT 400 WORDS)
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-16829, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-17734, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-1846449, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-1901717, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-1905146, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2213586, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2272082, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2317553, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2324427, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2352830, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2411338, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2436111, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2457695, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2457696, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2481034, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2483099, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2560389, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2560391, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2642011, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2758243, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2792371, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2819334, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-2843772, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3155026, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3192003, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3272181, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3341781, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3392676, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3443095, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3607452, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-3838314, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-4541078, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-5120393, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6122211, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6261668, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6286050, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6294290, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6310410, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6482502, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6760380, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6767024, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-6965523, http://linkedlifedata.com/resource/pubmed/commentcorrection/1403809-7279296
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:volume
451
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
159-85
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Kinetic and pharmacological properties of the M-current in rodent neuroblastoma x glioma hybrid cells.
pubmed:affiliation
Department of Pharmacology, University College London.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't